BSX
Price
$99.73
Change
-$0.80 (-0.80%)
Updated
Oct 21, 12:10 PM (EDT)
Capitalization
148.96B
One day until earnings call
Intraday Buy/Sell Signals
SYK
Price
$379.31
Change
-$1.92 (-0.50%)
Updated
Oct 21, 12:00 PM (EDT)
Capitalization
145.74B
9 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BSX vs SYK

Header iconBSX vs SYK Comparison
Open Charts BSX vs SYKBanner chart's image
Boston Scientific
Price$99.73
Change-$0.80 (-0.80%)
Volume$8.93K
Capitalization148.96B
Stryker
Price$379.31
Change-$1.92 (-0.50%)
Volume$500
Capitalization145.74B
BSX vs SYK Comparison Chart in %
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. SYK commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and SYK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (BSX: $100.53 vs. SYK: $381.22)
Brand notoriety: BSX: Notable vs. SYK: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BSX: 100% vs. SYK: 107%
Market capitalization -- BSX: $148.96B vs. SYK: $145.74B
BSX [@Medical/Nursing Services] is valued at $148.96B. SYK’s [@Medical/Nursing Services] market capitalization is $145.74B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $225.41B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 2 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • SYK’s FA Score: 2 green, 3 red.
According to our system of comparison, SYK is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 5 bullish TA indicator(s).

  • BSX’s TA Score: 4 bullish, 6 bearish.
  • SYK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SYK is a better buy in the short-term than BSX.

Price Growth

BSX (@Medical/Nursing Services) experienced а +5.88% price change this week, while SYK (@Medical/Nursing Services) price change was +4.47% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +24.59%. For the same industry, the average monthly price growth was +5.17%, and the average quarterly price growth was +22.85%.

Reported Earning Dates

BSX is expected to report earnings on Oct 22, 2025.

SYK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (+24.59% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($149B) and SYK($146B) have the same market capitalization . BSX has higher P/E ratio than SYK: BSX (59.84) vs SYK (50.49). BSX YTD gains are higher at: 12.550 vs. SYK (6.593). SYK has higher annual earnings (EBITDA): 5.76B vs. BSX (4.65B). BSX has less debt than SYK: BSX (12B) vs SYK (16.6B). SYK has higher revenues than BSX: SYK (23.8B) vs BSX (18.5B).
BSXSYKBSX / SYK
Capitalization149B146B102%
EBITDA4.65B5.76B81%
Gain YTD12.5506.593190%
P/E Ratio59.8450.49119%
Revenue18.5B23.8B78%
Total Cash534MN/A-
Total Debt12B16.6B72%
FUNDAMENTALS RATINGS
BSX vs SYK: Fundamental Ratings
BSX
SYK
OUTLOOK RATING
1..100
1911
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
619
SMR RATING
1..100
6457
PRICE GROWTH RATING
1..100
5455
P/E GROWTH RATING
1..100
6522
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (64) in the Medical Specialties industry is in the same range as BSX (81). This means that SYK’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (6) in the Medical Specialties industry is in the same range as SYK (19). This means that BSX’s stock grew similarly to SYK’s over the last 12 months.

SYK's SMR Rating (57) in the Medical Specialties industry is in the same range as BSX (64). This means that SYK’s stock grew similarly to BSX’s over the last 12 months.

BSX's Price Growth Rating (54) in the Medical Specialties industry is in the same range as SYK (55). This means that BSX’s stock grew similarly to SYK’s over the last 12 months.

SYK's P/E Growth Rating (22) in the Medical Specialties industry is somewhat better than the same rating for BSX (65). This means that SYK’s stock grew somewhat faster than BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXSYK
RSI
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
55%
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
55%
MACD
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
54%
Declines
ODDS (%)
Bearish Trend 9 days ago
46%
Bearish Trend 6 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
61%
Aroon
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GENW12.540.29
+2.33%
Genter Capital International Div ETF
GTEK39.930.57
+1.44%
Goldman Sachs Future Tech Leaders Eq ETF
NUKZ70.590.32
+0.46%
Range Nuclear Renaissance ETF
HYG80.880.16
+0.20%
iShares iBoxx $ High Yield Corp Bd ETF
THTA15.00N/A
N/A
SoFi Enhanced Yield ETF